Analysts predict a bumpy road for medical technology companies over the coming year
This article was originally published in Clinica
Analysts at US bancorp Piper Jaffray say that the device business will see smaller companies make deals as the larger companies digest what they bought. The US FDA is in "stressed mode" and reimbursement worldwide is an ever-present problem. A report from the New York conference by Imogen Daulby.